A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics
Translating preclinical safety findings into reliable insights for human risk assessment remains a fundamental challenge in drug development. Prior preclinical-clinical concordance studies have been constrained by limited drug coverage, reliance on identical-term matching for adverse events (AEs), a...
| Published in: | Frontiers in Toxicology |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2026-04-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/ftox.2026.1731947/full |
